Form 8-K - Current report:
SEC Accession No. 0001193125-22-302302
Filing Date
2022-12-12
Accepted
2022-12-12 08:03:47
Documents
38
Period of Report
2022-12-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d421322d8k.htm   iXBRL 8-K 26415
2 EX-99.1 d421322dex991.htm EX-99.1 20384
3 EX-99.2 d421322dex992.htm EX-99.2 27291
8 GRAPHIC g421322ex99_2p10g1.jpg GRAPHIC 303545
9 GRAPHIC g421322ex99_2p11g1.jpg GRAPHIC 341446
10 GRAPHIC g421322ex99_2p12g1.jpg GRAPHIC 271350
11 GRAPHIC g421322ex99_2p13g1.jpg GRAPHIC 343448
12 GRAPHIC g421322ex99_2p14g1.jpg GRAPHIC 213698
13 GRAPHIC g421322ex99_2p15g1.jpg GRAPHIC 318263
14 GRAPHIC g421322ex99_2p16g1.jpg GRAPHIC 349222
15 GRAPHIC g421322ex99_2p17g1.jpg GRAPHIC 255750
16 GRAPHIC g421322ex99_2p18g1.jpg GRAPHIC 180571
17 GRAPHIC g421322ex99_2p19g1.jpg GRAPHIC 272120
18 GRAPHIC g421322ex99_2p1g1.jpg GRAPHIC 317800
19 GRAPHIC g421322ex99_2p20g1.jpg GRAPHIC 298850
20 GRAPHIC g421322ex99_2p21g1.jpg GRAPHIC 260691
21 GRAPHIC g421322ex99_2p22g1.jpg GRAPHIC 216570
22 GRAPHIC g421322ex99_2p2g1.jpg GRAPHIC 547950
23 GRAPHIC g421322ex99_2p3g1.jpg GRAPHIC 252633
24 GRAPHIC g421322ex99_2p4g1.jpg GRAPHIC 298599
25 GRAPHIC g421322ex99_2p5g1.jpg GRAPHIC 379675
26 GRAPHIC g421322ex99_2p6g1.jpg GRAPHIC 197833
27 GRAPHIC g421322ex99_2p7g1.jpg GRAPHIC 292351
28 GRAPHIC g421322ex99_2p8g1.jpg GRAPHIC 441614
29 GRAPHIC g421322ex99_2p9g1.jpg GRAPHIC 348150
30 GRAPHIC g421322g1210044300258.jpg GRAPHIC 2734
  Complete submission text file 0001193125-22-302302.txt   9485731

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cogt-20221211.xsd EX-101.SCH 2777
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cogt-20221211_def.xml EX-101.DEF 13565
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cogt-20221211_lab.xml EX-101.LAB 22599
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cogt-20221211_pre.xml EX-101.PRE 14413
32 EXTRACTED XBRL INSTANCE DOCUMENT d421322d8k_htm.xml XML 5078
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38443 | Film No.: 221456193
SIC: 2834 Pharmaceutical Preparations